Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 12, 2026
Microsoft (MSFT) Surges +29.8% in 30 Days: Earnings Fuel Sharp Reversal

Microsoft (MSFT) Surges +29.8% in 30 Days: Earnings Fuel Sharp Reversal

Key Takeaways

  • Microsoft shares surged approximately 29.8% in the 30-day period through early August 2026, moving from around $385 to nearly $500.
  • The explosive rally was triggered by Microsoft's fiscal Q4 2026 earnings on July 29, which beat consensus estimates across revenue, earnings, and cloud growth.
  • Azure revenue growth accelerated to 43% year-over-year, and the cloud platform surpassed $100 billion in annual revenue for the first time.
  • Microsoft 365 Copilot reached over 30 million paid seats, signaling accelerating enterprise AI adoption.
  • The company slightly lowered its calendar 2026 capital expenditure outlook, easing investor anxiety around AI infrastructure spending.
  • Prior to earnings, MSFT was down roughly 19% year-to-date; the post-earnings surge erased those losses and turned the stock positive for 2026.

Microsoft (MSFT) Overview and Market Position

Microsoft Corporation stands as one of the largest technology companies globally, with operations spanning cloud computing, enterprise software, artificial intelligence, gaming, and professional networking. Its Microsoft Cloud platform, which includes Azure, Microsoft 365, Dynamics 365, and LinkedIn, accounts for well over half of total revenue. Azure goes head-to-head with AMZN Web Services and GOOGL Cloud in the hyperscale market, while the AI-powered Copilot suite places the company at the forefront of enterprise AI adoption. With a market capitalization near $3.7 trillion, MSFT remains a core holding for institutions and a key indicator of broader technology spending trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Microsoft (MSFT) Stock Price Performance: Last 30 Days vs. Quarter

Over the past 30 days, MSFT shares rose roughly 29.8%, advancing from a close of $385.10 on July 10 to $499.99 on August 7. The majority of the move occurred in one session on July 30, when the stock jumped 15.5%—its largest single-day gain since 2020—and added an estimated $483 billion in market value. That one-day increase even topped the prior record held by NVDA.

The quarterly view shows a clear reversal. Through late July 2026, MSFT had faced ongoing pressure and was down about 19% year-to-date amid questions over whether heavy AI infrastructure spending would deliver sufficient returns. The stock had traded in a narrow $370–$400 range for much of June and July until the earnings catalyst produced a sharp upward re-rating. The quarterly trend therefore reflects a pronounced V-shaped recovery driven by renewed confidence in Microsoft’s AI monetization path. From what I see, this kind of rapid shift highlights how earnings can quickly alter market perception.

What Drove MSFT Stock Price in the Last 30 Days

The main driver was Microsoft’s fiscal fourth-quarter 2026 earnings release after the close on July 29. Revenue reached $90.01 billion, up 18% year-over-year and well above the $87.62 billion consensus. Adjusted earnings per share came in at $4.74, beating the $4.24 estimate by about 12%.

Azure stood out once again. Azure and other cloud services revenue grew 43% year-over-year, accelerating from 40% in the prior quarter and exceeding expectations of roughly 39.6%. For the full fiscal year, Azure revenue crossed the $100 billion mark for the first time. CEO Satya Nadella noted that Microsoft 365 Copilot had surpassed 30 million paid seats, with net seat additions more than doubling sequentially.

Equally significant, the company addressed spending concerns that had pressured the stock earlier in the year. While reaffirming its commitment to AI infrastructure, Microsoft lowered its calendar 2026 capital expenditure outlook from around $190 billion to $175 billion, citing an accounting change that extends the useful life of data center assets. Commercial remaining performance obligations (RPO) jumped 84% year-over-year to $678 billion, pointing to substantial locked-in future revenue. CFO Amy Hood guided for Azure growth of about 45% in constant currency for fiscal Q1 2027, above consensus, and confirmed expectations for double-digit revenue and operating income growth for the full fiscal year. I’m watching this closely as it shows the company balancing growth with disciplined spending.

What Drove MSFT Stock Performance Over the Last Quarter

Microsoft’s quarterly results reflected an extended period of investor doubt followed by a strong earnings-driven rebound. For much of April through early July, the stock underperformed the broader market and many large-cap peers. The key concern was that aggressive AI capital expenditures—reaching $41 billion in the fourth quarter alone—were outpacing near-term revenue gains. Weak cash-flow reports from peers such as GOOGL and TSLA added to sector-wide pressure on AI-related names.

The July 29 earnings release changed the narrative decisively. Azure’s reacceleration indicated that AI workloads are moving from pilots to large-scale production deployments. The record RPO figure and Copilot’s growing seat count showed enterprise customers committing to longer-term AI adoption on the Microsoft platform. The fact that sequential RPO growth came from customers beyond frontier AI labs suggested broadening demand. Taken together, accelerating growth, solid forward guidance, and tempered spending expectations produced a powerful re-rating that reshaped the quarterly trajectory.

MSFT Stock Forecast Drivers: What Investors Should Watch Next

Looking forward, the next major catalyst is Microsoft’s fiscal first-quarter 2027 earnings report, expected in late October 2026. Investors will focus on whether Azure can maintain the guided 45% constant-currency growth and whether Copilot seat expansion continues at its current pace. Broader macroeconomic factors, including enterprise IT budgets and interest-rate policy, will shape cloud spending. Competitive moves by AMZN and GOOGL in AI infrastructure also merit attention. Regulatory developments, such as the UK Competition and Markets Authority investigation into Microsoft 365 practices opened in late July, remain relevant. Microsoft’s custom Maia AI accelerator chips could support margins if scaled successfully, though execution carries risk. The path of capital expenditures relative to free cash flow will stay central to debates about the pace and returns of the AI buildout. One thing that stands out is how these factors could influence the stock’s next leg higher or lower.

Exploring Tickeron’s AI Trading Bots

In my own research, I’ve found Tickeron’s AI Trading Bots helpful for testing automated strategies across different market conditions. The platform offers a range of bots with varying approaches, from short-term pattern recognition to longer-term trend following, each evaluated on historical performance and risk metrics. This allows users to explore data-driven options that align with their own risk parameters and time horizons.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSFT

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MSFT in upward trend: price rose above 50-day moving average on July 30, 2026

MSFT moved above its 50-day moving average on July 30, 2026 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on MSFT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for MSFT crossed bullishly above the 50-day moving average on July 31, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MSFT advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 274 cases where MSFT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSFT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MSFT broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MSFT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.453) is normal, around the industry mean (24.057). P/E Ratio (28.067) is within average values for comparable stocks, (74.273). Projected Growth (PEG Ratio) (1.645) is also within normal values, averaging (1.911). Dividend Yield (0.007) settles around the average of (0.021) among similar stocks. P/S Ratio (11.312) is also within normal values, averaging (134.061).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.26B. The market cap for tickers in the group ranges from 48.8K to 3.74T. MSFT holds the highest valuation in this group at 3.74T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 0%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 27%. AIFA experienced the highest price growth at 94%, while GYGY experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
MSFT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of software and harware products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
One Microsoft Way
Phone
+1 425 882-8080
Employees
228000
Web
https://www.microsoft.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.